|Bid||1.4200 x 800|
|Ask||1.4400 x 1800|
|Day's Range||1.4000 - 1.4305|
|52 Week Range||0.5300 - 1.8600|
|Beta (5Y Monthly)||0.71|
|PE Ratio (TTM)||155.56|
|Earnings Date||Sep 10, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.50|
Total First Half Fiscal 2020 Revenues of $5.7 million; $2.5 million Net Income; Adjusted EBITDA ($1.0 million) Atlanta, GA, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the eValuator™ Revenue Integrity Program to help healthcare providers proactively address revenue leakage and compliance exposure, today announced financial results for the second quarter and first half of fiscal 2020, which ended July 31, 2020.Total revenues for the second quarter of fiscal 2020 were $2.9 million, an increase of approximately 16% compared to $2.5 million in the prior year period. SaaS revenue was up $254,000, or 46%, over the same quarter a year ago. The revenue growth during the period was primarily attributable to higher perpetual revenue and new eValuator customers offset by lower professional services revenues which were negatively impacted by the COVID-19 pandemic. Recurring revenue comprised 70% of second quarter fiscal 2020 revenue compared to 73% of second quarter fiscal 2019 revenue.For the first six months of fiscal 2020, total revenue was $5.7 million, up $78,000 compared to the first six months of fiscal 2019. SaaS revenue was up $474,000, or 40%, over the first six months of fiscal 2019. Recurring revenue comprised 72% of revenue for the first six months of fiscal 2020 compared to 69% during the prior year period.Net loss for the second quarter of fiscal 2020 was ($1.1 million) as compared to a ($0.6 million) net loss during the second quarter of fiscal 2019. Second quarter fiscal 2020 net loss included a $28,000 gain from discontinued operations, in connection with the sale of the Company’s legacy ECM business which closed February 24, 2020, compared to a $1.0 million gain from discontinued operations during the second quarter of fiscal 2019. Gain from discontinued operations was offset by loss from continuing operations for the three months ended July 31, 2020 and 2019 of $1.2 million and $1.7 million, respectively.The company recorded $2.5 million of net income for the six months ended July 31, 2020, compared to a net loss of ($0.3 million) during the same period of 2019. First half fiscal 2020 net income included a $4.7 million gain from discontinued operations, in connection with the sale of the Company’s legacy ECM business which closed February 24, 2020, compared to a $2.0 million gain from discontinued operations during the first half of fiscal 2019. Gain from discontinued operations was offset by loss from continuing operations for the first six months of fiscal 2020 of ($2.1 million) as compared to ($2.3 million) for the same period in 2019.Adjusted EBITDA for the second quarter of fiscal 2020 was a loss of ($0.4 million), compared to an adjusted EBITDA loss of ($1.4 million) in the second quarter of fiscal 2019. For the six months ended July 31, 2020, adjusted EBITDA was a loss of ($1.0 million) compared to an adjusted EBITDA loss of ($1.7 million) during the first six months of fiscal 2019.“Our admiration and respect for the country’s healthcare workers continues to grow as the effects of the novel coronavirus linger. We remain grateful for their incredible commitment to the health of the communities they serve,” stated Tee Green, President and Chief Executive Officer, Streamline Health.“We are pleased to report incremental growth of our eValuator client base during the period, while our management team continued to successfully control expenses. Our sales team is gaining traction into a robust prospect pipeline and our reseller opportunities are expanding.”“Even with the continuing negative financial impact the Coronavirus pandemic is having on our industry, the progress we are making and the performance we are generating builds our confidence that we are on the right path. With our eValuator automated, cloud-based, pre-bill coding analysis technology, we will lead an industry-wide movement to help healthcare providers improve revenue integrity.”Highlights from the second quarter ended July 31, 2020 included: * Revenue for the second quarter of 2020 was $2.9 million; SaaS revenue was up $254,000 for the second quarter; * Loss from continuing operations for the second quarter of 2020 was ($1.2 million); * Adjusted EBITDA for the second quarter of 2020 was ($0.4 million); * Bookings for the second quarter of 2020 were $2.9 million.Conference CallThe Company will conduct a conference call to review the results on Thursday, September 10, 2020 at 9:00 AM ET. Interested parties can access the call by joining the live webcast: click here to register. You can also join by phone by dialing 877-269-7756.A replay of the conference call will be available from Thursday, September 10, 2020 at 12:00 PM ET to Thursday, September 17, 2020 at 12:00 PM ET by dialing 877-660-6853 or 201-612-7415 with conference ID 13708474. An online replay of the presentation will also be available for six months following the presentation in the Investor Relations section of the Streamline Health website, www.streamlinehealth.net.Non-GAAP Financial MeasuresStreamline Health reports its financial results in accordance with U.S. generally accepted accounting principles ("GAAP"). Streamline Health's management also evaluates and makes operating decisions using various other measures. One such measure is adjusted EBITDA, which is a non-GAAP financial measure. Streamline Health's management believes that this measure provides useful supplemental information regarding the performance of Streamline Health's business operations.Streamline Health defines "adjusted EBITDA" as net earnings (loss) plus interest expense, tax expense, depreciation and amortization expense of tangible and intangible assets, stock-based compensation expense, significant non-recurring operating expenses, and transactional related expenses including: gains and losses on debt and equity conversions, associate severances and related restructuring expenses, associate inducements, and professional and advisory fees. A table illustrating this measure is included in this press release.About Streamline HealthStreamline Health Solutions, Inc. (NASDAQ: STRM) is a leader in pre-bill revenue integrity solutions for healthcare providers. Our eValuator™ Revenue Integrity Program includes integrated solutions, technology-enabled services and analytics that drive compliant revenue across the enterprise. We share a common calling and commitment to advance the quality of life and the quality of healthcare - for society, our clients, the communities they serve, and the individual patient. For more information, please visit our website at www.streamlinehealth.net.Safe Harbor statement under the Private Securities Litigation Reform Act of 1995Statements made by Streamline Health Solutions, Inc. that are not historical facts are forward-looking statements that are subject to certain risks, uncertainties and important factors that could cause actual results to differ materially from those reflected in the forward-looking statements included herein. Forward-looking statements contained in this press release include, without limitation, statements regarding the Company's growth prospects, estimates of backlog, industry trends and market growth, results of investments in sales and marketing, adjusted EBITDA, success of future products and related expectations and assumptions. These risks and uncertainties include, but are not limited to, the timing of contract negotiations and execution of contracts and the related timing of the revenue recognition related thereto, the potential cancellation of existing contracts or clients not completing projects included in the backlog, the impact of competitive solutions and pricing, solution demand and market acceptance, new solution development and enhancement of current solutions, key strategic alliances with vendors and channel partners that resell the Company's solutions, the ability of the Company to control costs, the effects of cost-containment measures implemented by the Company, availability of solutions from third party vendors, the healthcare regulatory environment, potential changes in legislation, regulation and government funding affecting the healthcare industry, healthcare information systems budgets, availability of healthcare information systems trained personnel for implementation of new systems, as well as maintenance of legacy systems, fluctuations in operating results, effects of critical accounting policies and judgments, changes in accounting policies or procedures as may be required by the Financial Accounting Standards Board or other similar entities, changes in economic, business and market conditions impacting the healthcare industry generally and the markets in which the Company operates and nationally, and the Company's ability to maintain compliance with the terms of its credit facilities, and other risks detailed from time to time in the Streamline Health Solutions, Inc. filings with the U. S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's analysis only as of the date hereof. The Company undertakes no obligation to publicly release the results of any revision to these forward-looking statements, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.Contact Randy Salisbury SVP, Chief Sales & Marketing Officer (404) 229-4242 Randy.firstname.lastname@example.orgSTREAMLINE HEALTH SOLUTIONS, INC. CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Three Months Ended Six Months Ended July 31 July 31 2020 2019 2020 2019 Revenues: Systems sales$ 215,000 $ 111,000 $ 215,000 $ 332,000 Professional services 179,000 203,000 360,000 658,000 Audit Services 463,000 354,000 1,007,000 749,000 Maintenance and support 1,228,000 1,273,000 2,486,000 2,725,000 Software as a service 802,000 548,000 1,663,000 1,189,000 Total revenues 2,887,000 2,489,000 5,731,000 5,653,000 Operating expenses: Cost of systems sales 125,000 27,000 202,000 91,000 Cost of professional services 293,000 462,000 557,000 888,000 Cost of audit services 373,000 321,000 733,000 624,000 Cost of maintenance and support 182,000 176,000 368,000 303,000 Cost of software as a service 379,000 140,000 761,000 247,000 Selling, general and administrative 2,284,000 2,402,000 4,576,000 4,823,000 Research and development 509,000 660,000 1,193,000 1,249,000 Executive Transition Costs - 140,000 - 140,000 Loss on exit of membership agreement - - 105,000 - Total operating expenses 4,145,000 4,328,000 8,495,000 8,365,000 Operating loss (1,258,000) (1,839,000) (2,764,000) (2,712,000) Other expense: Interest expense (13,000) (70,000) (27,000) (148,000) Miscellaneous expense (64,000) (103,000) (82,000) (119,000) Loss before income taxes (1,335,000) (2,012,000) (2,873,000) (2,979,000) Income tax benefit 172,000 356,000 733,000 681,000 Loss from continuing operations$(1,163,000) $(1,656,000) $(2,140,000) $(2,298,000) Income from discontinued operations: Gain on sale of discontinued operations 4,000 - 6,013,000 - Income from discontinued operations 104,000 1,406,000 241,000 2,688,000 Income tax benefit (expense) (80,000) (358,000) (1,576,000) (685,000) Income from discontinued operations 28,000 1,048,000 4,678,000 2,003,000 Net (loss) income$(1,135,000) $ (608,000) $ 2,538,000 $ (295,000) Basic Earnings per Share: Continuing operations$ (0.04) $ (0.08) $ (0.07) $ (0.12) Discontinued operations - 0.05 0.16 0.09 Net (loss) income per share$ (0.04) $ (0.03) $ 0.09 $ (0.03) Weighted average number of common shares - basic 30,026,658 19,913,658 29,897,236 19,853,510 Diluted Earnings per Share: Continuing operations$ (0.04) $ (0.08) $ (0.07) $ (0.12) Discontinued operations - 0.05 0.15 0.09 Net (loss) income per share$ (0.04) $ (0.03) $ 0.08 $ (0.03) Weighted average number of common shares – diluted 30,421,473 23,076,807 30,229,595 22,950,923 STREAMLINE HEALTH SOLUTIONS, INC. CONSOLIDATED BALANCE SHEETS (Unaudited)Assets July 31, January 31, 2020 2020 Current assets: Cash and cash equivalents$ 5,707,000 $ 1,649,000 Accounts receivable, net 418,000 2,016,000 Contract receivables 1,193,000 803,000 Prepaid hardware and other current assets 747,000 501,000 Current Assets from discontinued operations 154,000 1,585,000 Total current assets 8,219,000 6,554,000 Non-current assets: Property and equipment, net 101,000 98,000 Right of use asset on operating lease 473,000 - Capitalized software development costs, net 6,263,000 5,782,000 Intangible assets, net 868,000 1,115,000 Goodwill 10,712,000 10,712,000 Other non-current assets 1,611,000 611,000 Long-term assets from discontinued operations 42,000 6,826,000 Total non-current assets 20,070,000 25,144,000 $ 28,289,000 $ 31,698,000 Liabilities and Stockholders' Equity Current liabilities: Accounts payable$ 121,000 $ 756,000 Accrued expenses 1,892,000 1,395,000 Current portion of term loan 1,071,000 3,872,000 Deferred revenues 3,149,000 3,593,000 Royalty liability 1,000,000 969,000 Other 195,000 - Current liabilities from discontinued operations 190,000 5,053,000 Total current liabilities 7,618,000 15,638,000 Non-current liabilities: Term loan, net of current portion 1,229,000 - Deferred revenues, less current portion 36,000 55,000 Other liabilities 309,000 - Total non-current liabilities 1,574,000 55,000 Total liabilities 9,192,000 15,693,000 Stockholders' equity 19,097,000 16,005,000 $ 28,289,000 $ 31,698,000 STREAMLINE HEALTH SOLUTIONS, INC. CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) Six Months Ended July 31, 2020 2019 Cash flows from continuing operating activities: Loss from continuing operations $ (2,140,000) $ (2,298,000) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation 31,000 22,000 Amortization of capitalized software development costs 651,000 236,000 Amortization of intangible assets 247,000 285,000 Amortization of other deferred costs 153,000 136,000 Valuation adjustments 31,000 31,000 Loss on exit of membership agreement 105,000 - Share-based compensation expense 575,000 429,000 Benefit for accounts receivable allowance (15,000) (125,000) Benefit for income taxes (733,000) (683,000) Changes in assets and liabilities (876,000) (1,108,000) Net cash used in operating activities (1,971,000) (3,075,000) Net cash from operating activities - discontinued operations (2,374,000) 3,164,000 Cash flows used in investing activities: Purchases of property and equipment (34,000) (46,000) Capitalization of software development costs (1,094,000) (1,543,000) Proceeds from sale of ECM assets 11,288,000 - Net cash provided by (used in) investing activities 10,160,000 (1,589,000) Net cash used in investing activities - discontinued operations - (335,000) Cash flows from financing activities: Proceeds from term loan 2,301,000 1,000,000 Principal payments on term loan (4,000,000) (298,000) Other (58,000) (14,000) Net cash used in financing activities (1,757,000) 688,000 Net decrease in cash and cash equivalents 4,058,000 (1,147,000) Cash and cash equivalents at beginning of year 1,649,000 2,376,000 Cash and cash equivalents at end of year $ 5,707,000 $ 1,229,000 STREAMLINE HEALTH SOLUTIONS, INC. New Bookings (Unaudited) July 31, 2020 Three Months Ended Six Months Ended Systems Sales$ 245,000$ 337,000 Professional Services 236,000 414,000 Audit Services 26,000 35,000 Maintenance and Support 283,000 311,000 Software as a Service 2,075,000 2,773,000 Q2 2020 Bookings$ 2,865,000$ 3,870,000 Q2 2019 Bookings (1)$ 3,603,000$ 4,726,000 (1) July 31, 2019 excludes bookings from the ECM business of approximately $180,000 for the three months ended July 31, 2019 and $280,000 for the six months ended July 31, 2019.Reconciliation of net earnings (loss) to non-GAAP Adjusted EBITDA (in thousands): (Unaudited)Adjusted EBITDA Reconciliation Three Months Ended July 31, Six Months Ended July 31, 2020 2019 2020 2019 Loss from continuing operations$ (1,163) $ (1,656) $ (2,140) $ (2,298) Interest expense 13 70 27 148 Income tax benefit (172) (356) (733) (681) Depreciation 17 14 31 22 Amortization of capitalized software development costs 362 110 651 236 Amortization of intangible assets 124 142 247 285 Amortization of other costs 78 70 153 136 EBITDA (741) (1,606) (1,764) (2,152) Share-based compensation expense 349 160 613 429 Non-cash valuation adjustments 14 16 31 31 Loss on exit of operating lease - - 105 - Adjusted EBITDA$ (378) $ (1,430) $ (1,015) $ (1,692) Adjusted EBITDA per diluted share: Net loss per common share – diluted$ (0.04) $ (0.03) $ 0.08 $ (0.03) Adjusted EBITDA per adjusted diluted share (1)$ (0.01) $ (0.07) $ (0.03) $ (0.09) Diluted weighted average shares (2) 30,026,658 19,913,658 29,897,236 19,853,510 Includable incremental shares — Adjusted EBITDA (3) 394,815 3,163,149 332,359 3,097,413 Adjusted diluted shares 30,421,473 23,076,807 30,229,595 22,950,923 (1) Adjusted EBITDA per adjusted diluted share for our common stock is computed using the more dilutive of the two-class method or the if-converted method. (2) Diluted EPS for our common stock was computed using the if-converted method, which yields the same result as the two-class method. (3) The number of incremental shares that would be dilutive under an assumption that the Company is profitable during the reported period, which is only applicable for a period in which the Company reports a GAAP net loss. If a GAAP profit is earned in the reported periods, no additional incremental shares are assumed.
Streamline Health Solns (NASDAQ: STRM) releases its next round of earnings this Wednesday, September 09. Get the latest predictions in Benzinga's essential guide to the company's Q2 earnings report.Earnings and Revenue Analysts covering Streamline Health Solns have modeled for quarterly EPS loss of $0.05 on revenue of $2.27 million. In the same quarter last year, Streamline Health Solns reported a loss per share of $0.02 on revenue of $4.79 million. The Wall Street consensus estimate for earnings per share would represent a 150.0% decrease for the company. Here's how the company's EPS has stacked up against analyst estimates in the past:Quarter Q1 2020 Q4 2020 Q3 2020 Q2 2019 EPS Estimate -0.06 -0.05 0.03 0.01 EPS Actual -0.03 -0.03 0.01 -0.02 Revenue Estimate 2.58 M 2.94 M 5.66 M 4.70 M Revenue Actual 2.84 M 4.80 M 5.79 M 4.79 M Stock Performance Over the past 52-week period, shares of Streamline Health Solns have declined 10.38%.View more earnings on STRMConsidering these returns, long-term shareholders will likely be feeling unsatisfied going into this earnings release.Don't be surprised to see the stock move on comments made during its conference call. Streamline Health Solns is scheduled to hold the call at 09:00:00 ET and can be accessed here: https://78449.themediaframe.com/dataconf/productusers/strm/mediaframe/40237/indexl.htmlSee more from Benzinga * Stocks That Hit 52-Week Highs On Tuesday(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Automated Coding Analysis for Inpatient and Outpatient CareAtlanta, GA, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the eValuator™ Revenue Integrity Program to help healthcare providers proactively address revenue leakage and compliance exposure, today announced it has signed a contract with a large health system in the Mid-Atlantic region. The health system will use eValuator’s cloud-based automated pre- and post-bill coding analysis technology to help improve revenue integrity for their inpatient and outpatient services.Streamline Health is leading an industry movement to enable every hospital in the country to use pre-bill technology to improve financial performance. With eValuator, providers are identifying and addressing coding issues before they contribute to revenue leakage, denied claims and non-compliance exposure. The company combines this new technology with expert auditing services to deliver a complete Revenue Integrity Program to its clients. The eValuator program helps users optimize coding and documentation accuracy for every patient encounter prior to billing, substantially improving current financial performance while also assisting in the transition to new payment models.“We’re very excited that this client has entrusted Streamline Health to be their partner in driving pre-bill revenue integrity,” stated Tee Green, President and Chief Executive Officer, Streamline Health. “This client’s flagship facility is an Academic Medical Center and the primary care provider for its surrounding communities, and we’re proud to help support their mission of delivering quality care during these trying times.”About Streamline HealthStreamline Health Solutions, Inc. (NASDAQ: STRM) is a leader in pre-bill revenue integrity solutions for healthcare providers. Our eValuator™ Revenue Integrity Program includes integrated solutions, technology-enabled services and analytics that drive compliant revenue across the enterprise. We share a common calling and commitment to advance the quality of life and the quality of healthcare - for society, our clients, the communities they serve, and the individual patient. For more information, please visit our website at www.streamlinehealth.net.Disclosure Regarding Client RelationshipsThis announcement may contain statements regarding the availability and sale of solution offerings from Streamline Health Solutions, Inc. Readers should understand that inherent risks in contractual relationships, such as changes in duration, scope or volume and similar unanticipated events, may come into play, and readers are cautioned to consider such factors in any reliance on these statements.Company Contact: Randy Salisbury SVP, Chief Sales & Marketing Officer (404) 229-4242 email@example.com